Oura Reportedly Plans September IPO at $16 Billion Valuation

Smart ring manufacturer Oura is reportedly preparing for a September U.S. initial public offering, with the potential to value the company at over $16 billion USD. The wearable health brand aims to raise up to $3 billion USD in this offering, as its projected annual sales are nearing the $2 billion USD mark. This move follows a confidential IPO filing earlier this year and signifies a significant growth period for the Finnish company.

Oura's Chief Executive Officer, Tom Hale, recently stated that the company anticipates generating close to $2 billion USD in revenue for the year 2026. This revenue projection is attributed to the company's ongoing international expansion efforts and the integration of advanced artificial intelligence coaching features into its products. The Oura smart ring, which began as a niche tool for biohackers, has successfully transitioned into a mainstream health monitoring device. Since its introduction, Oura has sold over 5.5 million units globally.

In its push towards preventative healthcare, Oura has recently introduced an AI chatbot. This development is complemented by ongoing research into glucose monitoring and blood pressure tracking, further solidifying its position in the health tech sector. The competitive landscape for wearable health technology is intensifying, with major players entering the market. Samsung launched its Galaxy Ring, targeting the Android user base, while rival fitness band company Whoop has broadened its appeal by introducing hormone tracking and blood-panel testing services to attract a wider demographic.

The potential IPO valuation of over $16 billion USD for Oura reflects investor confidence in the growing market for wearable health technology and Oura's established presence within it. The company's strategy of integrating AI and expanding its health monitoring capabilities beyond basic activity tracking appears to be a key driver for this valuation. The planned offering size of up to $3 billion USD would represent a substantial capital infusion, likely to fuel further research and development, international market penetration, and potentially acquisitions. Existing investors are anticipated to divest a notable portion of their holdings during the IPO process, which is a common practice in large public offerings.